While we observed trends in reduced Ki67 + /CD24 + and Ki67 + /CD44 + cell populations in response to JAK1 and STAT3 inhibition post-treatment, these differences did not reach statistical significance ( Figure 6 A–C).
← all excerpts
CD44 Marks Dormant Tumor Cells After HER2 Inhibition in Breast Cancer Cells.
1
—
—